Milestone reflects accelerating adoption of innovative, non-surgical treatment options for uterine conditionsTORONTO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ...

Francis Medical, Inc., a privately-held medical device company, announced the first commercial procedure using the Vanquish Water Vapor Ablation System at Pinnacle Surgery Center in Austin, Texas, by ...

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

What key experiences or clinical gaps motivated your focus on advancing prostate cancer diagnostics, particularly MRI-led ...

Down almost 70% from all-time highs, Profound Medical is an undervalued growth stock that offers significant upside potential ...

Market OverviewThe global transrectal ultrasound (TRUS) market is experiencing consistent expansion and is projected to grow at a compound annual growth rate of around 6% during the forecast period.

The results are in from those medical tests you took last week, and they might as well be written in Sanskrit. You could ...

Everyone’s body is different, and what may work for one patient in surgery may not work for another. Doctors at Tampa General ...

Heriot-Watt spin-out Less Grey Imaging is shortlisted for a major health technology award for its AI-driven prostate cancer imaging innovation.

On 16 January 2026, Telix Pharmaceuticals announced that the first U.S. patient had been dosed in BiPASS, a Phase 3 trial evaluating Illuccix and Gozellix PSMA-PET imaging alongside MRI for initial ...

A world-first study shows stabilised hyaluronic acid gel can safely protect the rectum during radiation therapy for ...

A Johns Hopkins University team is developing a low-cost, accurate, non-invasive test for diagnosing anemia using AI ...